123 related articles for article (PubMed ID: 15668599)
1. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study.
Barrett-Connor E; Laughlin GA
Menopause; 2005; 12(1):40-8. PubMed ID: 15668599
[TBL] [Abstract][Full Text] [Related]
2. Differences in association of bone mineral density with coronary artery calcification in men and women: the Rancho Bernardo Study.
Bakhireva LN; Barrett-Connor EL; Laughlin GA; Kritz-Silverstein D
Menopause; 2005; 12(6):691-8. PubMed ID: 16278612
[TBL] [Abstract][Full Text] [Related]
3. Visceral adiposity and subclinical coronary artery disease in elderly adults: Rancho Bernardo Study.
Kim DJ; Bergstrom J; Barrett-Connor E; Laughlin GA
Obesity (Silver Spring); 2008 Apr; 16(4):853-8. PubMed ID: 18356852
[TBL] [Abstract][Full Text] [Related]
4. Physical activity, hormone replacement therapy, and the presence of coronary calcium in midlife women.
Weinberg N; Young A; Hunter CJ; Agrawal N; Mao S; Budoff MJ
Women Health; 2012; 52(5):423-36. PubMed ID: 22747181
[TBL] [Abstract][Full Text] [Related]
5. Association between serum estradiol level and coronary artery calcification in postmenopausal women.
Jeon GH; Kim SH; Yun SC; Chae HD; Kim CH; Kang BM
Menopause; 2010; 17(5):902-7. PubMed ID: 20512078
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement on progression of coronary calcium as measured by electron beam tomography.
Budoff MJ; Chen GP; Hunter CJ; Takasu J; Agrawal N; Sorochinsky B; Mao S
J Womens Health (Larchmt); 2005 Jun; 14(5):410-7. PubMed ID: 15989413
[TBL] [Abstract][Full Text] [Related]
7. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.
Buller JC; Kritz-Silverstein D; Barrett-Connor E; Wingard D
J Womens Health; 1998 Feb; 7(1):49-56. PubMed ID: 9511132
[TBL] [Abstract][Full Text] [Related]
8. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
9. Thiazide-associated metabolic abnormalities and estrogen replacement therapy: an epidemiological analysis of postmenopausal women in Rancho Bernardo, California.
Saxman KA; Barrett-Connor EL; Morton DJ
J Clin Endocrinol Metab; 1994 May; 78(5):1059-63. PubMed ID: 8175960
[TBL] [Abstract][Full Text] [Related]
10. Lack of association of lipoprotein(a) levels with coronary calcium deposits in asymptomatic postmenopausal women.
Nishino M; Malloy MJ; Naya-Vigne J; Russell J; Kane JP; Redberg RF
J Am Coll Cardiol; 2000 Feb; 35(2):314-20. PubMed ID: 10676675
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy, lipoprotein subclasses, and coronary calcification: the Healthy Women Study.
Mackey RH; Kuller LH; Sutton-Tyrrell K; Evans RW; Holubkov R; Matthews KA
Arch Intern Med; 2005 Mar; 165(5):510-5. PubMed ID: 15767525
[TBL] [Abstract][Full Text] [Related]
12. Subclinical coronary atherosclerosis in asymptomatic Filipino and white women.
Araneta MR; Barrett-Connor E
Circulation; 2004 Nov; 110(18):2817-23. PubMed ID: 15505100
[TBL] [Abstract][Full Text] [Related]
13. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women.
Christian RC; Liu PY; Harrington S; Ruan M; Miller VM; Fitzpatrick LA
J Clin Endocrinol Metab; 2006 Jul; 91(7):2713-20. PubMed ID: 16608893
[TBL] [Abstract][Full Text] [Related]
14. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
[TBL] [Abstract][Full Text] [Related]
15. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
Hodis HN; Mack WJ; Lobo RA; Shoupe D; Sevanian A; Mahrer PR; Selzer RH; Liu Cr CR; Liu Ch CH; Azen SP;
Ann Intern Med; 2001 Dec; 135(11):939-53. PubMed ID: 11730394
[TBL] [Abstract][Full Text] [Related]
16. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study.
Mahoney LT; Burns TL; Stanford W; Thompson BH; Witt JD; Rost CA; Lauer RM
J Am Coll Cardiol; 1996 Feb; 27(2):277-84. PubMed ID: 8557894
[TBL] [Abstract][Full Text] [Related]
17. Lower extremity arterial disease in older women: the Rancho Bernardo Study.
Yeh ST; Morton DJ; Barrett-Connor E
J Womens Health Gend Based Med; 2000 May; 9(4):373-80. PubMed ID: 10868609
[TBL] [Abstract][Full Text] [Related]
18. Coronary Artery Calcification (CAC) and Post-Trial Cardiovascular Events and Mortality Within the Women's Health Initiative (WHI) Estrogen-Alone Trial.
Poornima IG; Mackey RH; Allison MA; Manson JE; Carr JJ; LaMonte MJ; Chang Y; Kuller LH;
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29079563
[TBL] [Abstract][Full Text] [Related]
19. Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators.
Robinson JC; Folsom AR; Nabulsi AA; Watson R; Brancati FL; Cai J
Diabetes Care; 1996 May; 19(5):480-5. PubMed ID: 8732713
[TBL] [Abstract][Full Text] [Related]
20. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
